Intervene early to lower the risk of endometrial hyperplasia and cancer
Dr Anne Connolly outlines the importance of understanding risk factors and early opportunities to intervene for endometrial hyperplasia and cancer
Improving cancer recognition and referral in primary care
Dr Anthony Cunliffe outlines the new service specifications for primary care networks, and explains how they will facilitate earlier diagnosis of cancer
Supporting primary care to recognise cancer in the COVID-19 era
Dr Anthony Cunliffe discusses barriers to cancer diagnosis and investigations imposed by the pandemic and how to overcome them
Top tips: mental health and cancer in adults
Dr Sadaf Haque offers 10 top tips for primary care on the identification and management of mental health problems in adults with cancer
Top tips: colorectal cancer
Dr Richard Roope provides top tips for GPs about identifying possible colorectal cancer and supporting patients to reduce risk and achieve the best outcomes
Top tips: personalising cancer care
Dr Anthony Cunliffe shares 10 top tips for primary care on the provision of personalised care for people with cancer
Our multiple-choice questions (MCQs) are designed to help you test your knowledge and reflect on your learning after reading an article.
Reflecting on endometrial hyperplasia and cancer
Use this reflective template to reflect on your learning after reading Intervene early to lower the risk of endometrial hyperplasia and cancer.
Reflecting on cancer recognition and referral
Use this reflective template to reflect on your learning after reading Improving cancer recognition and referral in primary care.
Best practice in pancreatic cancer
This CPD activity consists of 5 multiple-choice questions (MCQs) designed to test your knowledge on pancreatic cancer in primary care—you will then be prompted to reflect on your learning.
Educational resources
Disease-modifying anti-rheumatic drugs (DMARDS) guidelines: a focus on methotrexate guidance in clinical practice
Information intended for UK healthcare professionals only. This webinar was initiated and commissioned by Accord-UK Ltd and developed in partnership with Guidelines in Practice.
View Methofill® (methotrexate) pre-filled injector and pre-filled syringe prescribing information and adverse event reporting information here
View the Summary of Product Characteristics for Folic Acid 5mg Tablets; Legal Cat POM; NHS List price 90p
UK-02645
Date of preparation: September 2021
Real-world usage study and survey of oral bowel cleansing for colonoscopy in Dudley, UK
This supplement has been commissioned by Norgine Pharmaceuticals Limited and contains promotional information. Information for healthcare professionals only.
Click here for PLENVU® (macrogol 3350, sodium ascorbate, ascorbic acid, sodium sulfate anhydrous, potassium chloride, sodium chloride) Prescribing and Adverse Event Reporting.
Click here for MOVIPREP® ((macrogol 3350, sodium sulfate anhydrous, ascorbic acid, sodium ascorbate, sodium chloride, and potassium chloride) Prescribing and Adverse Event Reporting.
Click here for KLEAN-PREP (macrogol 3350, anhydrous sodium sulfate, sodium bicarbonate, sodium chloride, potassium chloride) Prescribing and Adverse Event Reporting.
UK-GE-PLV-2000027
Date of preparation: February 2021
Related Guidelines summaries
-
NICE pancreatic cancer guidance
What is the GP’s role in the management of pancreatic cancer? This summary covers recognition and referral, diagnosis, and psychological support
-
NICE cancer recognition and referral guideline
Updated summary of guidance to assist GPs in the recognition of several cancers, and referral to specialist care for further investigation
-
PHE caries, gum disease, and oral cancer prevention guidance
A short summary of guidance to equip community pharmacy teams with advice for patients of all ages on caries, periodontal disease, and oral cancer prevention
-
RPS cancer support guideline
A summary of initiatives that utilise the skill mix of community pharmacy teams to support people with cancer within the community
-
COVID-19 rapid guideline on systemic anticancer treatments
This summary aims to maximise the safety of patients with cancer and make the best use of NHS resources, while protecting staff from infection